Spasticity is a common symptom in MS patients. It is easy to recognize and
evaluate spasticity at rest. The efficacy of numerous treatments has been w
ell documented. Nevertheless, it is difficult, particularly in MS patients,
to assess the functional disability due to spasticity and the functional b
enefit due to treatment. This is why it is appears more appropriate to use
therapeutic tests with transitory effects such as anesthetic blocks in case
of focal spasticity or intrathetcal baclofen in case of diffuse spasticity
. It is also possible to use reversible treatments such as botulinum toxin
injections before proposing section of a peripheral nerve.